Safety and effectiveness of the combination of remimazolam tosilate and propofol in gastroscopy: a multicenter, randomized controlled, single-blind clinical trial

Remimazolam tosilate (RT) is a new short-acting γ-aminobutyric acid A (GABAA) receptors agonist. However, its optimal use mode and dosage still remain unclear. This study aimed to examine the safety and effectiveness of the combination of RT and propofol in gastroscopy. This was a prospective, singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chunyan, Gao, Yangzheng, Li, Jie, Zhang, Linlin, Li, Qing, Li, Yize, Lu, Yuechun, Sun, Jiangang, Zhang, Yang, Cheng, Yaobei, Zhang, Shidong, Wang, Guolin, Yu, Yonghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264591/
https://www.ncbi.nlm.nih.gov/pubmed/37324493
http://dx.doi.org/10.3389/fphar.2023.1124667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264591/
https://www.ncbi.nlm.nih.gov/pubmed/37324493
http://dx.doi.org/10.3389/fphar.2023.1124667

Ejemplares similares